Director, Epidemiology
Moderna, Inc.
Disclosure(s): Director, Moderna, Inc.: Employee, Stocks/Bonds (Public Company)
Christine Kim, PhD, MPH, is Director of Epidemiology for the Norovirus Program at Moderna. In this role, she supports the epidemiology strategy the norovirus vaccine program, including genomic surveillance partnerships, real-world evidence generation, and clinical trial epidemiology. Dr. Kim has over a decade of experience in epidemiology, with prior work in the public sector spanning vaccine-preventable diseases in low and middle income countries, antibiotic stewardship, and maternal and child health.